Aprea Therapeutics, Inc. · NASDAQ:APRE
Aprea Therapeutics, Inc. shareholders
As of Sep 30, 2026, 27 institutions reported holding Aprea Therapeutics, Inc., 23.6% of its shares. Largest: AIGH Capital Management LLC, Soleus Capital Management, L.P. and Vestal Point Capital, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aprea Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| AIGH Capital Management LLC | 1.02M | 7.2% | no change | Nov 2, 2026 |
| Soleus Capital Management, L.P. | 1M | 7.0% | new | Nov 16, 2026 |
| Vestal Point Capital, LP | 350K | 2.5% | no change | Nov 16, 2026 |
| Sphera Funds Management LTD. | 270K | 1.9% | no change | Nov 16, 2026 |
| Nantahala Capital Management, LLC | 206K | 1.4% | −206K | Nov 13, 2026 |
| Renaissance Technologies | 99,600 | 0.70% | −6,200 | Nov 12, 2026 |
| Vanguard | 87,676 | 0.62% | +26,330 | Nov 13, 2026 |
| Geode Capital | 74,549 | 0.53% | −320 | Nov 6, 2026 |
| BNP Paribas | 46,211 | 0.33% | +1,000 | Nov 12, 2026 |
| Virtu Financial LLC | 43,083 | 0.30% | new | Nov 17, 2026 |